儿童与青少年急诊非处方药中毒:COVID-19影响的全国性分析
共5907例,非处方药中毒发生率轻度上升(疫情期间vs疫情前IRR 1.64,95%CI 0.98-2.76;疫情后IRR 2.10,95%CI 1.22-3.61),但处方药中毒上升更陡(IRR分别为2.62和3.41)。非处方药占比从33.6%降至29.9%和29.3%(P=0.004),而镇静催眠药(22.7%至37.0%)和抗抑郁药(7.3%至10.0%)中毒增加。中断时间序列分析显示疫情开始时非处方药中毒立即显著下降,处方药中毒未下降。
要点
- 儿童青少年药物中毒总体上升主要由处方药(自伤)驱动,非处方药中毒占比反而从33.6%降至29.3%(P=0.004)。
- 非处方药中毒发生率疫情前后变化不显著(疫情期间IRR 1.64,95%CI 0.98-2.76),疫情后仅轻度升高(IRR 2.10,95%CI 1.22-3.61)。
- 处方药中毒上升更陡:疫情vs疫情前IRR 2.62,疫情后vs疫情前IRR 3.41(原文未给出95%CI)。
- 镇静催眠药中毒占比从22.7%升至37.0%,抗抑郁药从7.3%升至10.0%,提示自伤相关中毒增加。
- 中断时间序列分析显示疫情开始时非处方药中毒立即显著下降,支持维持韩国非药房渠道包装量限制。
适用人群与场景
- 18岁及以下儿童与青少年药物中毒患者,就诊于急诊科;数据来自韩国全国急诊伤害监测系统,涵盖疫情前、中、后三个时期。
- 原文未明确列出排除人群。
诊断标准与关键阈值
- 原文未提及具体诊断标准或关键阈值;研究以急诊就诊药物中毒病例为纳入依据。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及具体红旗征或需立即处理的情况。
研究设计与关键结果
- 非处方药中毒发生率轻度上升:疫情期间vs疫情前IRR 1.64(95%CI 0.98-2.76),疫情后vs疫情前IRR 2.10(95%CI 1.22-3.61)。
- 处方药中毒上升更陡:疫情期间vs疫情前IRR 2.62,疫情后vs疫情前IRR 3.41(原文未给出95%CI)。
- 非处方药占全部病例31.1%,占比从33.6%降至29.9%和29.3%(P=0.004);镇静催眠药中毒占比从22.7%升至37.0%,抗抑郁药从7.3%升至10.0%。
- 中断时间序列分析显示疫情开始时非处方药中毒立即显著下降,处方药中毒未下降。
证据类型、等级与局限
- 证据类型:基于全国监测系统的回顾性分析;原文未给出证据等级或推荐强度。
- 局限:回顾性设计;原文提及非处方药趋势稳定或下降可能反映韩国非药房渠道现有包装量限制,支持维持而非放松当前法规。
对床旁实践的改变
- 提示急诊/ICU医生:儿童青少年药物中毒上升主要由处方药(自伤)驱动,而非非处方药可及性;评估时应重点关注镇静催眠药和抗抑郁药中毒及自伤风险。
- 支持维持而非放松非处方药包装量限制等现有监管措施;原文未提及其他具体实践改变。
指南或共识出处
- 原文未提及指南或共识名称;研究数据来自韩国全国急诊伤害监测系统(Emergency Department-based Injury In-depth Surveillance system)。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Over-the-counter drug consumption rose during the COVID-19 pandemic, raising concern about a parallel increase in pediatric and adolescent over-the-counter drug poisoning. We compared over-the-counter and prescription drug poisoning patterns among patients aged 18 years or younger before, during, and after the pandemic.
METHODS: This retrospective analysis of the nationwide Emergency Department-based Injury In-depth Surveillance system (January 2017-December 2023) included patients aged 18 years or younger presenting with drug poisoning across pre-pandemic, pandemic, and post-pandemic periods. Incidence rate ratios (IRR) were estimated using Poisson regression with monthly emergency department visits as the offset, refitted as negative binomial when over-dispersion was present. Interrupted time series analysis evaluated over-the-counter drug poisoning trends.
RESULTS: Of 5,907 drug poisoning cases, the incidence rate of over-the-counter drug poisoning increased modestly (IRR for pandemic versus pre-pandemic 1.64, 95% CI 0.98-2.76; post-pandemic 2.10, 95% CI 1.22-3.61), whereas prescription drug poisoning rose more steeply (IRR 2.62 and 3.41, respectively). Over-the-counter drugs accounted for 31.1% of cases, with the proportion declining from 33.6% to 29.9% and 29.3% (P = 0.004), while tranquilizer (22.7% to 37.0%) and antidepressant (7.3% to 10.0%) poisoning increased.
DISCUSSION: The pandemic-related increase in drug poisoning was driven predominantly by prescription drugs used in self-harm rather than by over-the-counter drug accessibility. After accounting for the pre-existing secular trend, interrupted time series analysis showed a significant immediate decrease in over-the-counter drug poisoning at the pandemic onset, whereas prescription drug poisoning did not decline. The stable or declining over-the-counter trend may reflect existing packaging-quantity restrictions at non-pharmacy outlets in South Korea, supporting the maintenance rather than relaxation of current regulations.
CONCLUSION: Among pediatric and adolescent patients, over-the-counter drug poisoning declined while prescription drug poisoning rose significantly across the three periods. The pandemic-related increase reflected prescription rather than over-the-counter drugs.
参考来源
- Heo S, Jung KY. Over-the-counter drug poisoning among pediatric and adolescent patients presenting to emergency departments: a nationwide analysis of the COVID-19 impact. Clin Toxicol (Phila). 2026. PMID: 42495931. doi:10.1080/15563650.2026.2703877
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。